| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |||||
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||
| (Address of Principal Executive Offices) | (Zip Code) | |||||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
| Large accelerated filer | ☐ | x | |||||||||
| Non-accelerated filer | ☐ | Smaller reporting company | |||||||||
| Emerging growth company | |||||||||||
| Page | ||||||||
| Special Note Regarding Forward-Looking Statements | ||||||||
Legal Proceedings | ||||||||
| September 30, | December 31, | ||||||||||
| 2024 | 2023 | ||||||||||
| Assets | |||||||||||
| Current Assets | |||||||||||
| Cash and cash equivalents | $ | $ | |||||||||
Accounts receivable, net of allowance of $ | |||||||||||
| Prepaid expenses | |||||||||||
| Deferred charges | |||||||||||
| Other current assets | |||||||||||
| Total current assets | |||||||||||
| Restricted cash | |||||||||||
| Property and equipment, net | |||||||||||
| Capitalized software development costs, net | |||||||||||
| Intangible assets, net | |||||||||||
| Goodwill | |||||||||||
| Right-of-use assets | |||||||||||
| Other assets | |||||||||||
| Total assets | $ | $ | |||||||||
Liabilities and Stockholders’ Deficit | |||||||||||
Current Liabilities | |||||||||||
| Accounts payable | $ | $ | |||||||||
| Accrued expenses and other current liabilities | |||||||||||
| Current maturities of long-term debt, net | |||||||||||
| Deferred revenue | |||||||||||
| Total current liabilities | |||||||||||
| Long-term debt, net | |||||||||||
| Warrant liability | |||||||||||
| Lease liability | |||||||||||
| Deferred tax liability | |||||||||||
| Other non-current liabilities | |||||||||||
| Total liabilities | $ | $ | |||||||||
Commitments and Contingencies (Note 14) | |||||||||||
| Stockholders’ Deficit | |||||||||||
Preferred stock, par value $ | $ | $ | |||||||||
Common stock, par value $ | |||||||||||
Treasury stock | ( | ( | |||||||||
| Additional paid-in capital | |||||||||||
| Accumulated deficit | ( | ( | |||||||||
| Total stockholders’ deficit | $ | ( | $ | ( | |||||||
| Total liabilities and stockholders’ deficit | $ | $ | |||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
| Revenue | $ | $ | $ | $ | |||||||||||||||||||
| Operating costs and expenses | |||||||||||||||||||||||
Cost of revenue (exclusive of depreciation and amortization shown separately below) | |||||||||||||||||||||||
| Selling, general and administrative expense | |||||||||||||||||||||||
| Product development expense | |||||||||||||||||||||||
| Depreciation and amortization | |||||||||||||||||||||||
| Total operating expenses | |||||||||||||||||||||||
| Income from operations | |||||||||||||||||||||||
| Other income (expense) | |||||||||||||||||||||||
| Interest expense, net | ( | ( | ( | ( | |||||||||||||||||||
| Other income (expense), net | ( | ( | ( | ||||||||||||||||||||
| Gain (loss) in fair value of warrant liability | ( | ( | ( | ||||||||||||||||||||
| Total other income (loss), net | ( | ( | ( | ||||||||||||||||||||
| Net income (loss) before income tax | ( | ||||||||||||||||||||||
| Income tax provision | |||||||||||||||||||||||
| Net income (loss) and comprehensive income (loss) | $ | $ | ( | $ | ( | $ | ( | ||||||||||||||||
| Net income (loss) per share | |||||||||||||||||||||||
| Basic | $ | $ | $ | ( | $ | ( | |||||||||||||||||
| Diluted | $ | $ | $ | ( | $ | ( | |||||||||||||||||
| Weighted-average shares outstanding: | |||||||||||||||||||||||
| Basic | |||||||||||||||||||||||
| Diluted | |||||||||||||||||||||||
Preferred Stock (Par value $ | Common Stock (Par value $ | Treasury Stock | Additional paid-in capital | Accumulated deficit | Total stockholders’ equity (deficit) | ||||||||||||||||||||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | ||||||||||||||||||||||||||||||||||||||||||||||||
| Balance at December 31, 2022 | $ | $ | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||||||||||||||||||||
| Net loss and comprehensive loss | — | — | — | — | — | — | — | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
| Interest on the promissory note to a member | — | — | — | — | — | — | ( | — | ( | ||||||||||||||||||||||||||||||||||||||||||||
| Repayment of promissory note to a member | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||
| Payment of interest on promissory note to a member | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||
| Vested restricted stock units | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||
| Exercise of stock options | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||
| Balance at March 31, 2023 | $ | $ | $ | $ | $ | ( | $ | ( | |||||||||||||||||||||||||||||||||||||||||||||
| Net income and comprehensive income | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||
| Vested restricted stock units | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||
| Exercise of stock options | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||
| Balance at June 30, 2023 | $ | $ | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||||||||||||||||||||
| Net loss and comprehensive loss | — | — | — | — | — | — | — | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
| Pre-Closing entity income tax adjustment | — | — | — | — | — | — | ( | — | ( | ||||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||
| Vested restricted stock units | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||
| Exercise of stock options | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||
| Balance at September 30, 2023 | $ | $ | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock (Par value $ | Common Stock (Par value $ | Treasury Stock | Additional paid-in capital | Accumulated deficit | Total stockholders’ deficit | ||||||||||||||||||||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | ||||||||||||||||||||||||||||||||||||||||||||||||
| Balance at December 31, 2023 | $ | $ | $ | ( | $ | $ | ( | $ | ( | ||||||||||||||||||||||||||||||||||||||||||||
| Net loss and comprehensive loss | — | — | — | — | — | — | — | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||
| Vested restricted stock units | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||
| Exercise of stock options | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||
| Repurchase of common stock for net settlement of equity awards | — | — | — | — | ( | — | — | ( | |||||||||||||||||||||||||||||||||||||||||||||
| Balance at March 31, 2024 | $ | $ | $ | ( | $ | $ | ( | $ | ( | ||||||||||||||||||||||||||||||||||||||||||||
| Net loss and comprehensive loss | — | — | — | — | — | — | — | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||
| Vested restricted stock units | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||
| Exercise of stock options | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||
| Repurchase of common stock for net settlement of equity awards | — | — | — | — | ( | — | — | ( | |||||||||||||||||||||||||||||||||||||||||||||
| Balance at June 30, 2024 | $ | $ | $ | ( | $ | $ | ( | $ | ( | ||||||||||||||||||||||||||||||||||||||||||||
| Net income and comprehensive income | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||
| Vested restricted stock units | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||
| Exercise of stock options | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||
| Exercise of warrants | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||
| Repurchase of common stock for net settlement of equity awards | — | — | — | — | ( | — | — | ( | |||||||||||||||||||||||||||||||||||||||||||||
| Balance at September 30, 2024 | $ | $ | $ | ( | $ | $ | ( | $ | ( | ||||||||||||||||||||||||||||||||||||||||||||
| Nine Months Ended September 30, | |||||||||||
| 2024 | 2023 | ||||||||||
| Operating activities | |||||||||||
| Net loss and comprehensive loss | $ | ( | $ | ( | |||||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||||||||
| Stock-based compensation | |||||||||||
| Loss in fair value of warrant liability | |||||||||||
| Amortization of debt discount and issuance costs | |||||||||||
| Interest income on promissory note from member | ( | ||||||||||
| Depreciation and amortization | |||||||||||
| Provision for expected credit losses | ( | ||||||||||
| Deferred income taxes | ( | ( | |||||||||
| Non-cash lease expense | |||||||||||
| Changes in operating assets and liabilities: | |||||||||||
| Accounts receivable | ( | ( | |||||||||
| Prepaid expenses and deferred charges | ( | ||||||||||
| Other current assets | |||||||||||
| Other assets | ( | ( | |||||||||
| Accounts payable | ( | ( | |||||||||
| Accrued expenses and other current liabilities | |||||||||||
| Deferred revenue | |||||||||||
| Lease liability | ( | ( | |||||||||
| Other liabilities | |||||||||||
| Net cash provided by operating activities | |||||||||||
| Investing activities | |||||||||||
| Purchases of property and equipment | ( | ( | |||||||||
| Additions to capitalized software | ( | ( | |||||||||
| Net cash used in investing activities | ( | ( | |||||||||
| Financing activities | |||||||||||
| Proceeds from the exercise of stock options | |||||||||||
| Proceeds from the exercise of warrants | |||||||||||
| Principal payments on debt | ( | ( | |||||||||
| Withholding taxes paid on stock-based compensation | ( | ||||||||||
| Transaction costs paid in connection with the Business Combination | ( | ||||||||||
| Proceeds from the repayment of promissory note to a member including interest | |||||||||||
| Net cash (used in) provided by financing activities | ( | ||||||||||
| Net increase in cash, cash equivalents and restricted cash | |||||||||||
Cash, cash equivalents and restricted cash, beginning of the period | |||||||||||
| Cash, cash equivalents and restricted cash, end of the period | $ | $ | |||||||||
| Reconciliation of cash, cash equivalents and restricted cash | |||||||||||
| Cash and cash equivalents | $ | $ | |||||||||
| Restricted cash | |||||||||||
| Cash, cash equivalents and restricted cash | $ | $ | |||||||||
| Supplemental disclosure of cash flow information: | |||||||||||
| Cash interest paid | $ | $ | |||||||||
| Income taxes paid | $ | $ | |||||||||
| Supplemental disclosure of non-cash investing activities: | |||||||||||
| Capitalized software development costs accrued but not paid | $ | $ | |||||||||
| Supplemental disclosure of non-cash financing activities: | |||||||||||
| Repurchase of common stock for net settlement of equity awards | $ | $ | |||||||||
Level 1 - | Observable inputs obtained from independent sources, such as quoted market prices for identical assets and liabilities in active markets. | ||||
| Level 2 - | Other inputs, which are observable directly or indirectly, such as quoted market prices for similar assets or liabilities in active markets, quoted market prices for identical or similar assets or liabilities in markets that are not active, and inputs that are derived principally from or corroborated by observable market data. | ||||
| Level 3 - | Unobservable inputs for which there is little or no market data and require the Company to develop its own assumptions, based on the best information available in the circumstances, about the assumptions market participants would use in pricing the assets or liabilities. | ||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
| Direct revenue | $ | $ | $ | $ | |||||||||||||||||||
| Indirect revenue | |||||||||||||||||||||||
| $ | $ | $ | $ | ||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
North America (1) | $ | $ | $ | $ | |||||||||||||||||||
| Europe | |||||||||||||||||||||||
| Rest of the world | |||||||||||||||||||||||
| $ | $ | $ | $ | ||||||||||||||||||||
| September 30, 2024 | December 31, 2023 | ||||||||||
| Cloud computing arrangements implementation costs | $ | $ | |||||||||
| Income tax receivable | |||||||||||
| Other current assets | |||||||||||
| $ | $ | ||||||||||
| September 30, 2024 | December 31, 2023 | ||||||||||
| Employee compensation and benefits | $ | $ | |||||||||
| Litigation-related funds received from escrow (see Note 14) | |||||||||||
| Income and other taxes payable | |||||||||||
| Lease liability, short-term | |||||||||||
| Accrued professional service fees | |||||||||||
| Accrued infrastructure expense | |||||||||||
| Accrued legal expense | |||||||||||
| Accrued interest payable | |||||||||||
| Other accrued expenses | |||||||||||
| $ | $ | ||||||||||
| September 30, 2024 | December 31, 2023 | ||||||||||
| Senior Term Loan Facility | $ | $ | |||||||||
| Senior Revolving Facility | |||||||||||
| Less: unamortized debt issuance and discount costs | ( | ( | |||||||||
| Total debt | |||||||||||
| Less: current maturities of long-term debt | ( | ( | |||||||||
| Long-term debt | $ | $ | |||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
| Operating lease cost | $ | $ | $ | $ | |||||||||||||||||||
| Short-term lease cost | |||||||||||||||||||||||
| Sublease income | ( | ( | ( | ( | |||||||||||||||||||
| Total lease cost | $ | $ | $ | $ | |||||||||||||||||||
| Nine Months Ended September 30, | |||||||||||
| 2024 | 2023 | ||||||||||
| Cash paid for amounts included in the measurement of lease liabilities | $ | $ | |||||||||
| Right-of-use assets obtained in exchange for lease liabilities: | |||||||||||
| New lease entered into during the year | $ | $ | |||||||||
| September 30, 2024 | December 31, 2023 | ||||||||||
| Assets: | |||||||||||
| Right-of-use assets | $ | $ | |||||||||
| Liabilities: | |||||||||||
| Lease liability, long-term portion | |||||||||||
| Total operating lease liabilities | $ | $ | |||||||||
| Weighted average remaining operating lease term (years) | |||||||||||
| Weighted average operating lease discount rate | |||||||||||
| Remainder of 2024 | $ | ||||
| 2025 | |||||
| 2026 | |||||
| Thereafter | |||||
| Total lease payments | $ | ||||
| Less: imputed interest | ( | ||||
| Total lease liabilities | $ | ||||
| Remainder of 2024 | $ | ||||
| 2025 | |||||
| 2026 | |||||
| Thereafter | |||||
| $ | |||||
| September 30, 2024 | December 31, 2023 | ||||||||||
| Expected term (in years) | |||||||||||
Expected stock price volatility (1) | % | % | |||||||||
Risk-free interest rate (2) | % | % | |||||||||
Expected dividend yield (3) | % | % | |||||||||
| Number of Shares | Weighted Average Grant Date Fair Value | ||||||||||
| Outstanding at December 31, 2023 | $ | ||||||||||
| Granted | $ | ||||||||||
| Vested | ( | $ | |||||||||
| Forfeited | ( | $ | |||||||||
| Outstanding at September 30, 2024 | $ | ||||||||||
| Number of Options | Weighted Average Exercise Price | ||||||||||
| Outstanding at December 31, 2023 | $ | ||||||||||
| Exercised | ( | $ | |||||||||
Forfeited or expired | ( | $ | |||||||||
| Outstanding at September 30, 2024 | $ | ||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
| Selling, general and administrative expenses | $ | $ | $ | $ | |||||||||||||||||||
| Product development expenses | $ | $ | $ | ||||||||||||||||||||
| $ | $ | $ | $ | ||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
| Numerator: | |||||||||||||||||||||||
| Net income (loss) and comprehensive income (loss) | $ | $ | ( | $ | ( | $ | ( | ||||||||||||||||
Gain on fair value of warrant liabilities | ( | ||||||||||||||||||||||
| Net income (loss) and comprehensive income (loss) adjusted for gain on fair value of warrant liabilities | $ | $ | ( | $ | ( | $ | ( | ||||||||||||||||
| Denominator: | |||||||||||||||||||||||
Basic weighted average shares of common stock outstanding | |||||||||||||||||||||||
Diluted effect of stock-based awards | |||||||||||||||||||||||
Diluted effect of warrants | |||||||||||||||||||||||
Diluted weighted average shares of common shares outstanding | |||||||||||||||||||||||
| Net income (loss) per share | |||||||||||||||||||||||
Basic | $ | $ | $ | ( | $ | ( | |||||||||||||||||
Diluted | $ | $ | $ | ( | $ | ( | |||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
| Stock options issued under 2020 Plan | |||||||||||||||||||||||
| Time-based RSUs | |||||||||||||||||||||||
| Public and Private Warrants | |||||||||||||||||||||||
| September 30, 2024 | |||||||||||||||||||||||
| Total | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||
| Assets: | |||||||||||||||||||||||
| Money market funds | $ | $ | $ | $ | |||||||||||||||||||
| Liabilities: | |||||||||||||||||||||||
Common stock warrant liabilities | $ | $ | $ | $ | |||||||||||||||||||
| December 31, 2023 | |||||||||||||||||||||||
| Total | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||
| Assets: | |||||||||||||||||||||||
| Money market funds | $ | $ | $ | $ | |||||||||||||||||||
| U.S. treasury bonds | |||||||||||||||||||||||
| $ | $ | $ | $ | ||||||||||||||||||||
| Liabilities: | |||||||||||||||||||||||
Common stock warrant liabilities | $ | $ | $ | $ | |||||||||||||||||||
| Public Warrants | Private Warrants | Total Warrant Liability | |||||||||||||||
| Fair value as of December 31, 2023 | $ | $ | $ | ||||||||||||||
| Change in fair value of warrant liability | |||||||||||||||||
| Exercise of warrants | ( | ( | |||||||||||||||
| Fair value as of September 30, 2024 | $ | $ | $ | ||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| (in thousands, except ARPPU and ARPU) | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||
| Key Operating Metrics | |||||||||||||||||||||||
| Average Paying Users | 1,111 | 962 | 1,057 | 919 | |||||||||||||||||||
Average Monthly Active Users (“Average MAUs”) | 14,554 | 13,468 | 14,103 | 13,142 | |||||||||||||||||||
Average Paying User Penetration | 7.6 | % | 7.1 | % | 7.5 | % | 7.0 | % | |||||||||||||||
Average Direct Revenue per Average Paying User (“ARPPU”) | $ | 23.07 | $ | 21.33 | $ | 22.20 | $ | 19.69 | |||||||||||||||
Average Total Revenue per User (“ARPU”) | $ | 2.05 | $ | 1.74 | $ | 1.95 | $ | 1.59 | |||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| ($ in thousands) | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||
Key Financial and Non-GAAP Metrics(1) | |||||||||||||||||||||||
| Revenue | $ | 89,325 | $ | 70,258 | $ | 247,015 | $ | 187,605 | |||||||||||||||
| Direct revenue | $ | 76,907 | $ | 61,575 | $ | 211,203 | $ | 162,886 | |||||||||||||||
| Indirect revenue | $ | 12,418 | $ | 8,683 | $ | 35,812 | $ | 24,719 | |||||||||||||||
| Net income (loss) | $ | 24,681 | $ | (437) | $ | (7,149) | $ | (11,005) | |||||||||||||||
| Net income (loss) margin | 27.6 | % | (0.6) | % | (2.9) | % | (5.9) | % | |||||||||||||||
| Adjusted EBITDA | $ | 40,144 | $ | 32,601 | $ | 108,696 | $ | 81,484 | |||||||||||||||
| Adjusted EBITDA Margin | 44.9 | % | 46.4 | % | 44.0 | % | 43.4 | % | |||||||||||||||
| Net cash provided by operating activities | $ | 29,125 | $ | 8,313 | $ | 65,424 | $ | 23,116 | |||||||||||||||
| Operating cash flow conversion | 118.0 | % | (1,902.3) | % | (915.1) | % | (210.0) | % | |||||||||||||||
| Free cash flow | $ | 27,882 | $ | 7,399 | $ | 61,337 | $ | 19,627 | |||||||||||||||
| Free cash flow conversion | 69.5 | % | 22.7 | % | 56.4 | % | 24.1 | % | |||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||||||||||||||||||||||||||
| ($ in thousands) | 2024 | % of Total Revenue | 2023 | % of Total Revenue | 2024 | % of Total Revenue | 2023 | % of Total Revenue | |||||||||||||||||||||||||||||||||||||||
| Revenue | $ | 89,325 | 100.0 | % | $ | 70,258 | 100.0 | % | $ | 247,015 | 100.0 | % | $ | 187,605 | 100.0 | % | |||||||||||||||||||||||||||||||
| Operating costs and expenses | |||||||||||||||||||||||||||||||||||||||||||||||
Cost of revenue (exclusive of depreciation and amortization shown separately below) | 22,915 | 25.7 | % | 18,243 | 26.0 | % | 63,534 | 25.7 | % | 49,168 | 26.2 | % | |||||||||||||||||||||||||||||||||||
| Selling, general and administrative expense | 24,976 | 28.0 | % | 16,420 | 23.4 | % | 76,387 | 30.9 | % | 52,523 | 28.0 | % | |||||||||||||||||||||||||||||||||||
| Product development expense | 8,806 | 9.9 | % | 13,270 | 18.9 | % | 22,301 | 9.0 | % | 24,976 | 13.3 | % | |||||||||||||||||||||||||||||||||||
| Depreciation and amortization | 4,241 | 4.7 | % | 5,753 | 8.2 | % | 12,595 | 5.1 | % | 21,845 | 11.6 | % | |||||||||||||||||||||||||||||||||||
| Total operating expenses | 60,938 | 68.2 | % | 53,686 | 76.4 | % | 174,817 | 70.8 | % | 148,512 | 79.2 | % | |||||||||||||||||||||||||||||||||||
| Income from operations | 28,387 | 31.8 | % | 16,572 | 23.6 | % | 72,198 | 29.2 | % | 39,093 | 20.8 | % | |||||||||||||||||||||||||||||||||||
| Other income (expense) | |||||||||||||||||||||||||||||||||||||||||||||||
| Interest expense, net | (6,400) | (7.2) | % | (11,985) | (17.1) | % | (20,254) | (8.2) | % | (35,695) | (19.0) | % | |||||||||||||||||||||||||||||||||||
| Other income (expense), net | 68 | 0.1 | % | (390) | (0.6) | % | (276) | (0.1) | % | (98) | (0.1) | % | |||||||||||||||||||||||||||||||||||
| Gain (loss) in fair value of warrant liability | 8,219 | 9.2 | % | (3,362) | (4.8) | % | (45,579) | (18.5) | % | (11,581) | (6.2) | % | |||||||||||||||||||||||||||||||||||
| Total other income (loss), net | 1,887 | 2.1 | % | (15,737) | (22.4) | % | (66,109) | (26.8) | % | (47,374) | (25.3) | % | |||||||||||||||||||||||||||||||||||
| Net income (loss) before income tax | 30,274 | 33.9 | % | 835 | 1.2 | % | 6,089 | 2.5 | % | (8,281) | (4.4) | % | |||||||||||||||||||||||||||||||||||
| Income tax provision | 5,593 | 6.3 | % | 1,272 | 1.8 | % | 13,238 | 5.4 | % | 2,724 | 1.5 | % | |||||||||||||||||||||||||||||||||||
| Net income (loss) and comprehensive income (loss) | $ | 24,681 | 27.6 | % | $ | (437) | (0.6) | % | $ | (7,149) | (2.9) | % | $ | (11,005) | (5.9) | % | |||||||||||||||||||||||||||||||
| Net income (loss) per share | |||||||||||||||||||||||||||||||||||||||||||||||
| Basic | $ | 0.14 | $ | — | $ | (0.04) | $ | (0.06) | |||||||||||||||||||||||||||||||||||||||
| Diluted | $ | 0.09 | $ | — | $ | (0.04) | $ | (0.06) | |||||||||||||||||||||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| ($ in thousands) | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||
Reconciliation of net income (loss) to Adjusted EBITDA | |||||||||||||||||||||||
| Net income (loss) | $ | 24,681 | $ | (437) | $ | (7,149) | $ | (11,005) | |||||||||||||||
| Interest expense, net | 6,400 | 11,985 | 20,254 | 35,695 | |||||||||||||||||||
Income tax provision | 5,593 | 1,272 | 13,238 | 2,724 | |||||||||||||||||||
| Depreciation and amortization | 4,241 | 5,753 | 12,595 | 21,845 | |||||||||||||||||||
Litigation-related costs (1) | 396 | 414 | 1,479 | 1,913 | |||||||||||||||||||
| Stock-based compensation expense | 7,052 | 3,648 | 22,642 | 10,594 | |||||||||||||||||||
Severance expense (2) | — | 6,744 | 58 | 8,077 | |||||||||||||||||||
Management fees (3) | — | (97) | — | (97) | |||||||||||||||||||
Change in fair value of warrant liability (4) | (8,219) | 3,362 | 45,579 | 11,581 | |||||||||||||||||||
Other (5) | — | (43) | — | 157 | |||||||||||||||||||
| Adjusted EBITDA | $ | 40,144 | $ | 32,601 | $ | 108,696 | $ | 81,484 | |||||||||||||||
| Revenue | $ | 89,325 | $ | 70,258 | $ | 247,015 | $ | 187,605 | |||||||||||||||
Net income (loss) margin | 27.6 | % | (0.6) | % | (2.9) | % | (5.9) | % | |||||||||||||||
| Adjusted EBITDA Margin | 44.9 | % | 46.4 | % | 44.0 | % | 43.4 | % | |||||||||||||||
Net cash provided by operating activities | $ | 29,125 | $ | 8,313 | $ | 65,424 | $ | 23,116 | |||||||||||||||
Less: | |||||||||||||||||||||||
Capitalized development software costs and purchases of property and equipment | (1,243) | (914) | (4,087) | (3,489) | |||||||||||||||||||
Free cash flow | $ | 27,882 | $ | 7,399 | $ | 61,337 | $ | 19,627 | |||||||||||||||
Operating cash flow conversion (6) | 118.0 | % | (1,902.3) | % | (915.1) | % | (210.0) | % | |||||||||||||||
Free cash flow conversion | 69.5 | % | 22.7 | % | 56.4 | % | 24.1 | % | |||||||||||||||
| Nine Months Ended September 30, | ||||||||||||||
| ($ in thousands) | 2024 | 2023 | ||||||||||||
| Cash, and cash equivalents, including restricted cash (as of the end of period) | $ | 39,725 | $ | 31,340 | ||||||||||
| Net cash provided by (used in): | ||||||||||||||
| Operating activities | $ | 65,424 | $ | 23,116 | ||||||||||
| Investing activities | (4,087) | (3,489) | ||||||||||||
| Financing activities | (50,610) | 1,596 | ||||||||||||
| Net change in cash and cash equivalents | $ | 10,727 | $ | 21,223 | ||||||||||
| Type of Trading Arrangement | ||||||||||||||||||||||||||||||||||||||
| Name and Position | Action | Adoption/Termination Date | Rule 10b5-1(1) | Non-Rule 10b5-1(2) | Total Shares of Common Stock to be Sold(3) | Expiration Date | ||||||||||||||||||||||||||||||||
Adoption | ||||||||||||||||||||||||||||||||||||||
| Adoption | ||||||||||||||||||||||||||||||||||||||
| Adoption | ||||||||||||||||||||||||||||||||||||||
| (1) | Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. | ||||
| (2) | “Non-Rule 10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K under the Exchange Act. | ||||
| (3) | Represents the maximum number of shares that may be sold pursuant to the Rule 10b5-1 arrangement. The actual number of shares sold will be dependent on the satisfaction of certain conditions as set forth in the written plan. | ||||
(4) | Includes | ||||
| Exhibit No. | Description | Form | File Number | Exhibit | Filing Date | |||||||||||||||||||||||||||
| Restated Certificate of Incorporation of Grindr Inc., dated November 18, 2022. | Form S-1/A | 333-268782 | 3.1 | February 9, 2023 | ||||||||||||||||||||||||||||
| Bylaws of Grindr Inc., dated November 18, 2022. | Form 8-K | 001-39714 | 3.2 | November 23, 2022 | ||||||||||||||||||||||||||||
| Grindr Inc. Amended and Restated 2022 Equity Incentive Plan and forms of award agreement thereunder. | Form 8-K | 001-39714 | 10.1 | July 25, 2024 | ||||||||||||||||||||||||||||
| Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||||||||||||||||||||||||||||||
| Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||||||||||||||||||||||||||||||
| Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||||||||||||||||||||||||||||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema with Embedded Linkbase Document | |||||||||||||||||||||||||||||||
| 104 | Cover page formatted as inline XBRL and contained in Exhibit 101 | |||||||||||||||||||||||||||||||
| GRINDR INC. | ||||||||
| By: | ||||||||
/s/ Vandana Mehta-Krantz | ||||||||
| Vandana Mehta-Krantz | ||||||||
Chief Financial Officer (Principal Financial Officer and Duly Authorized Signatory) | ||||||||